Near‐normalization of glycaemic control with glucagon‐like peptide‐1 receptor agonist treatment combined with exercise in patients with type 2 diabetes
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Aims To investigate the effects of exercise in combination with a glucagon‐like peptide‐1 receptor agonist ( GLP‐1RA ), liraglutide, or placebo for the treatment of type 2 diabetes. Methods Thirty‐three overweight, dysregulated and sedentary patients with type 2 diabetes were randomly allocated to 16 weeks of either exercise and liraglutide or exercise and placebo. Both groups had three supervised 60‐minute training sessions per week including spinning and resistance training. Results Glycated haemoglobin ( HbA1c ) levels dropped by a mean ± standard deviation of 2.0% ± 1.2% (from 8.2% ± 1.4%) in the exercise plus liraglutide group vs 0.3% ± 0.9% (from 8.0% ± 1.2%) in the exercise plus placebo group ( P < .001), and body weight was reduced more with liraglutide (−3.4 ± 2.9 kg vs −1.6 ± 2.3 kg; P < .001). Compared with baseline, similar reductions were seen in body fat (exercise plus liraglutide: −2.5% ± 1.4% [ P < .001]; exercise plus placebo: −2.2% ± 1.9% [ P < .001]) and similar increases were observed in maximum oxygen uptake (exercise plus liraglutide: 0.5 ± 0.5 L O 2 /min [ P < .001]; exercise plus placebo: 0.4 ± 0.4 L O 2 /min [ P = .002]). Greater reductions in fasting plasma glucose (−3.4 ± 2.3 mM vs −0.3 ± 2.6 mM , P < .001) and systolic blood pressure (−5.4 ± 7.4 mm Hg vs −0.6 ± 11.1 mm Hg , P < .01) were seen with exercise plus liraglutide vs exercise plus placebo. The two groups experienced similar increases in quality of life during the intervention. Conclusions In obese patients with type 2 diabetes, exercise combined with GLP‐1RA treatment near‐normalized HbA1c levels and caused a robust weight loss when compared with placebo. These results suggest that a combination of exercise and GLP‐1RA treatment is effective in type 2 diabetes.
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12797
Institutions: University of Copenhagen, Gentofte Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes, GLP-1 receptor agonists, liraglutide, exercise training, combination therapy, HbA1c, glycemic control, weight loss, fat loss, cardiorespiratory fitness, blood pressure, sedentary patients, quality of life, resistance training, cycling, obesity, fasting blood glucose, VO2max, quality-adjusted life years
Open Access status: hybrid
Estimated APC paid: $5,380
Awards: G1551214306, G2790715585, G4899559972
OpenAlex ID: W2527559853
